COVID-19: What to do now, what to do next

Accenture surveyed 720 healthcare providers (HCPs) globally on how operations and needs changed during COVID-19 and the effects for patients and pharmas.

Image Thumbnail


Is COVID-19 altering how pharma engages with HCPs?
Read More

Navigating the impact of COVID-19

Pivot to the patient

Life sciences is evolving rapidly from selling products to delivering value through better patient outcomes.

We work with our pharmaceutical, biotech, medical technology, distributor and consumer health clients globally to redefine the future of the life sciences industry: combining the latest technology with scientific breakthroughs to revolutionize how medical treatments are discovered, developed and delivered to patients around the world.

New science: Biopharma’s new growth engine

Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and deliver better patient outcomes.


New Science | Pharma's New Growth Machine

Accenture's video shows how New Science can reshape the biopharma landscape and patient care to overcome compressive disruption. See more.

View Transcript

Case studies

Accenture supports forces with Siemens Healthineers in digitizing its customer service processes.

Accenture helped a biopharma company implement a patient-centered platform to manage the delivery of a personalized gene therapy solution.

A new SAP S/4 HANA ERP solution ushers Merck KGaA Healthcare into a digital future.

View All

Awards & recognition

Our Life Sciences solutions are helping businesses deliver exceptional patient experiences. Discover how our awards distinguish us as an industry leader.


Global Healthcare Partner of the Year



Leader in Medical Devices Digital Services



Leader in Life Sciences Digital Services


View All

A spotlight on women in Life Sciences

We are proud to collaborate with leading women in Life Sciences in their quest to advance science and patient care.

Driven by a constant curiosity, Lisa Banks’ career has taken her many places, from starting out as a pharmacist in the UK, to moving halfway around the world to work in China, to now living and working in Belgium with her family. Currently Head of Digital Innovations for GSK Vaccines, Lisa is at the forefront of innovation, helping accelerate the identification and adoption of new technologies to support the full lifecycle of a vaccine – a timely role at a time when the world is faced with a pandemic. We sat down with Lisa to learn more about her career path, what drives her curiosity, and the importance of women in Life Sciences.


Life Sciences blog

Life Sciences consultants weigh in on how pharma, biotech, medtech and consumer health companies can improve patient outcomes.

Is COVID-19 changing our value proposition to HCPs?

As the pandemic stretches on, pharma companies have realized they need to do more than just communicate product information in order to be relevant.

The case for scaling AI in biopharma

AI is key for survival and growth - Our blog reveals strategies for successfully adopting transformation in biopharma.

Our events

Knowledge of trends and insights are important to Accenture. Join our live thought leader-hosted events and watch on-demand sessions.



Pharma Companies Have Improved How They Engage with Healthcare Providers During COVID-19

As a result of COVID-19, pharmaceutical companies are changing how they engage with healthcare providers.

Accenture named a leader in Everest Group’s Medical Devices Digital Services PEAK Matrix® Assessment 2020

Accenture is positioned as a Leader in medical devices digital services in a new report from independent research firm Everest Group.

Patients want to continue to use virtual care even after the pandemic ends, Accenture survey finds

Patients have embraced virtual care and communications at very high rates as a result of COVID-19.

Subscription Center
Stay in the Know with Our Newsletter Stay in the Know with Our Newsletter